PillRx only · Capsule, Delayed Release · Oral
Fenofibric Acid
Fenofibric Acid
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.220
Latest avg · Jul 22, 2026
+6%
Since Dec 17, 2025
8
Active US suppliers
51%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.5K
Rx · 2026 Q1
160K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 12 | SUPPLYING |
| Laurus Labs Limited | unknown | 6 | SUPPLYING |
| Micro Labs Limited | unknown | 5 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 4 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
| Leading Pharma, LLC | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 0 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.